Danielle Brill, PharmD

Danielle Brill joined Raymond James in 2020 to cover the biotechnology sector. Brill has previously worked in the medical field as a senior research technician and clinical pharmacist, and most recently was an equity research analyst at Needham & Company from 2015 to 2018 and at Piper Jaffray & Co. from 2018 to 2020. Brill completed her B.S. in human biology at Michigan State University and earned her Doctor of Pharmacy from the Ernest Mario School of Pharmacy at Rutgers University, graduating summa cum laude.